Adelaida Sara Zepeda

Prof. Dr. Adelaida Sara Zepeda


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
Tonatiuh Abimael Baltazar-DíazTonatiuh Abimael Baltazar-Díaz
Tonatiuh Abimael Baltazar-Díaz
LGLuz Alicia González-Hernández
Luz Alicia González-Hernández
JAJuan Manuel Aldana-Ledesma
Juan Manuel Aldana-Ledesma
MRMarcela Peña Rodríguez
Marcela Peña Rodríguez
Natali Vega-MagañaNatali Vega-Magaña
Natali Vega-Magaña
MBMiriam Ruth Bueno
Miriam Ruth Bueno
Gut microbiota undergoes profound alterations in alcohol cirrhosis. Microbiota-derived products, e.g., short chain fatty acids (SCFA), regulate the homeostasis of the gut-liver axis. The objective was to evaluate the composition and functions of the intestinal microbiota in patients with alcohol-decompensated cirrhosis. Fecal samples of 18 patients and 18 healthy controls (HC) were obtained. Microbial composition was characterized by 16S rRNA amplicon sequencing, SCFA quantification was performed by gas chromatography (GC), and metagenomic predictive profiles were analyzed by PICRUSt2. Gut microbiota in the cirrhosis group revealed a significant increase in the pathogenic/pathobionts genera Escherichia/Shigella and Prevotella, a decrease in beneficial bacteria, such as Blautia, Faecalibacterium, and a decreased α-diversity (p < 0.001) compared to HC. Fecal SCFA concentrations were significantly reduced in the cirrhosis group (p < 0.001). PICRUSt2 analysis indicated a decrease in acetyl-CoA fermentation to butyrate, as well as an increase in pathways related to antibiotics resistance, and aromatic amino acid biosynthesis. These metabolic pathways have been poorly described in the progression of alcohol-related decompensated cirrhosis. The gut microbiota of these patients possesses a pathogenic/inflammatory environment; therefore, future strategies to balance intestinal dysbiosis should be implemented. These findings are described for the first time in the population of western Mexico.

25 August 2023 in Medicina
Verified
Journal Article
Open access
PDF file
JMJulio César Muro-Valdez
Julio César Muro-Valdez
AMAlejandra Meza-Rios
Alejandra Meza-Rios
BUBlanca Rosa Rosa Aguilar Uscanga
Blanca Rosa Rosa Aguilar Uscanga
RRRocio Ivette Lopez Roa
Rocio Ivette Lopez Roa
EDEunice Medina Díaz
Eunice Medina Díaz
AZAdelaida Sara Zepeda
Adelaida Sara Zepeda
Breast milk (BM) is a constantly changing fluid that represents the primary source of nutrition for newborns. It is widely recognized that breastfeeding provides benefits for both the child and the mother, including a lower risk of ovarian and breast cancer, type 2 diabetes mellitus, decreased blood pressure, and more. In infants, breastfeeding has been correlated with a lower risk of infectious diseases, obesity, lower blood pressure, and decreased incidence of respiratory infections, diabetes, and asthma. Various factors, such as the baby’s sex, the health status of the mother and child, the mother’s diet, and the mode of delivery, can affect the composition of breast milk. This review focuses on the biological impact of the nutrients in BM on the development and functionality of vital organs to promote the benefit of health.

27 February 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
ASAlma Marina Sánchez Sánchez
Alma Marina Sánchez Sánchez
AZAdelaida Sara Zepeda
Adelaida Sara Zepeda
LQLucrecia Carrera Quintanar
Lucrecia Carrera Quintanar
JVJuan Manuel Viveros-Paredes
Juan Manuel Viveros-Paredes
NFNoel Noé Franco-Arroyo
Noel Noé Franco-Arroyo
RRRocio Ivette Lopez Roa
Rocio Ivette Lopez Roa
Obesity generates a chronic low-grade inflammatory state which promotes oxidative stress and triggers comorbidities. Alliin is the main organosulfur compound in garlic and has been shown to induce a decrease in the expression of proinflammatory cytokines; its systemic effect on metabolic parameters and adipose tissue is not yet known, however. After nine weeks of HFD and with obesity established in C57BL/6 mice, we observed that a daily treatment with alliin for 3.5 weeks (15 mg/kg) did not affect body weight, but significantly improved insulin sensitivity and glucose tolerance, both evaluated through a blood glucose monitoring system. Once alliin treatment was completed, serum, adipose tissue, and organs of interest related to metabolism were removed for further analysis. We observed that alliin significantly decreased the size of adipocytes from epididymal adipose tissue, evaluated via microscopy. A decrease in gene expression and serum protein levels of the adipocytokines leptin and resistin, as well as decreased serum IL-6 concentration, were detected by qRT-PCR and ELISA, respectively. It did not, however, affect mRNA expression of antioxidant enzymes in the liver. Taken altogether, these results indicate that treatment with alliin reduces metaflammation markers in DIO mice and improves some metabolic parameters without affecting others.

Verified
Journal Article
Open access
PDF file
LQLucrecia Carrera Quintanar
Lucrecia Carrera Quintanar
Daniel Ortuño-SahagúnDaniel Ortuño-Sahagún
Daniel Ortuño-Sahagún
NANoel Noé Franco Arroyo
Noel Noé Franco Arroyo
JVJuan M. Viveros-Paredes
Juan M. Viveros-Paredes
AZAdelaida Sara Zepeda
Adelaida Sara Zepeda
RRRocio Ivette Lopez Roa
Rocio Ivette Lopez Roa
Obesity is a noncommunicable disease that affects a considerable part of humanity. Recently, it has been recognized that gut microbiota constitutes a fundamental factor in the triggering and development of a large number of pathologies, among which obesity is one of the most related to the processes of dysbiosis. In this review, different animal model approaches, methodologies, and genome scale metabolic databases were revisited to study the gut microbiota and its relationship with metabolic disease. As a data source, PubMed for English-language published material from 1 January 2013, to 22 August 2018, were screened. Some previous studies were included if they were considered classics or highly relevant. Studies that included innovative technical approaches or different in vivo or in vitro models for the study of the relationship between gut microbiota and obesity were selected after a 16-different-keyword exhaustive search. A clear panorama of the current available options for the study of microbiota’s influence on obesity, both for animal model election and technical approaches, is presented to the researcher. All the knowledge generated from the study of the microbiota opens the possibility of considering fecal transplantation as a relevant therapeutic alternative for obesity and other metabolic disease treatment.

20 September 2022 in Molecules
Verified
Journal Article
Open access
PDF file
URUriel Ulises Rodríguez-Mejía
Uriel Ulises Rodríguez-Mejía
JVJuan Manuel Viveros-Paredes
Juan Manuel Viveros-Paredes
AZAdelaida Sara Zepeda
Adelaida Sara Zepeda
LQLucrecia Carrera Quintanar
Lucrecia Carrera Quintanar
JNJosé Sergio Zepeda Nuño
José Sergio Zepeda Nuño
RRRocio Ivette Lopez Roa
Rocio Ivette Lopez Roa
Obesity is an excessive accumulation of fat that exacerbates the metabolic and inflammatory processes. Studies associate these processes with conditions and dysregulation in the intestinal tract, increased concentrations of lipopolysaccharides (LPSs) in the blood, differences in the abundance of intestinal microbiota, and the production of secondary metabolites such as short-chain fatty acids. β-Caryophyllene (BCP) is a natural sesquiterpene with anti-inflammatory properties and with the potential purpose of fighting metabolic diseases. A diet-induced obesity model was performed in 16-week-old C57BL/6 mice administered with BCP [50 mg/kg]. A reduction in the expression of Claudin-1 was observed in the group with a high-fat diet (HFD), which was caused by the administration of BCP; besides BCP, the phylaAkkermansia and Bacteroidetes decreased between the groups with a standard diet (STD) vs. HFD. Nevertheless, the use of BCP in the STD increased the expression of these phyla with respect to fatty acids; a similar effect was observed, in the HFD group that had a decreasing concentration that was restored with the use of BCP. The levels of endotoxemia and serum leptin increased in the HFD group, while in the HFD + BCP group, similar values were found to those of the STD group, attributing the ability to reduce these in conditions of obesity.

28 October 2023 in Medicina
Verified
Journal Article
Open access
PDF file
AMAlejandra Meza-Rios
Alejandra Meza-Rios
ELErika Fabiola López-Villalobos
Erika Fabiola López-Villalobos
LALuis-Alberto Anguiano-Sevilla
Luis-Alberto Anguiano-Sevilla
SQSANDRA LUZ RUIZ QUEZADA
SANDRA LUZ RUIZ QUEZADA
GVGILBERTO Velázquez
GILBERTO Velázquez
AZAdelaida Sara Zepeda
Adelaida Sara Zepeda
Adipose tissue and liver metabolism play a key role in maintaining body homeostasis; therefore, their impairment conduces a pathological state. Nowadays, occidental lifestyle is a common etiological issue among a variety of chronic diseases, while diet is a unique strategy to prevent obesity and liver metabolism impairment and is a powerful player in the treatment of metabolic-related diseases. Mesoamerican foods are rich in bioactive molecules that enhance and improve adipose tissue and liver performance and represent a prophylactic and therapeutic alternative for disorders related to the loss of homeostasis in the metabolism of these two important tissues.